All Updates

All Updates

icon
Filter
M&A
Sidekick Health acquires PINK! to expand into oncology and women's health
Preventive Healthcare
Jun 18, 2024
This week:
Funding
EKORE raises EUR 1.3 million (~ USD 1 million) in seed funding to strengthen platform
Digital Twin
Yesterday
Funding
Culina Health raises USD 7.9 million in Series A funding to expand offerings and expand team
Functional Nutrition
Dec 19, 2024
FDA approval
ViGeneron receives IND clearance for VG801 gene therapy
Cell & Gene Therapy
Dec 19, 2024
Product updates
Reflex Aerospace ships first commercial satellite SIGI
Next-gen Satellites
Dec 19, 2024
Partnerships
Vast partners with SpaceX for two private astronaut missions to ISS
Space Travel and Exploration Tech
Dec 19, 2024
Management news
Carbios appoints Philippe Pouletty as interim CEO amid plant delay
Waste Recovery & Management Tech
Dec 19, 2024
Funding
BlueQubit raises USD 10 million in seed funding to develop quantum platform
Quantum Computing
Dec 19, 2024
FDA approval
Arbor Biotechnologies receives FDA clearance for ABO-101 IND application
Human Gene Editing
Dec 19, 2024
Funding
Partnerships
Personalis partners with Merck and Moderna for cancer therapy development and investment
Precision Medicine
Dec 19, 2024
Partnerships
COTA partners with Guardant Health to develop clinicogenomic data solutions for cancer research
Precision Medicine
Dec 19, 2024
Preventive Healthcare

Preventive Healthcare

Jun 18, 2024

Sidekick Health acquires PINK! to expand into oncology and women's health

M&A

  • Digital Therapeutics (DTx) company Sidekick Health has acquired PINK!, a digital health company specializing in cancer support and women's health, for an undisclosed sum.

  • The acquisition will allow Sidekick Health to integrate PINK!'s breast cancer digital therapeutic, PINK! Coach, into its portfolio. This will enable the company to offer a range of digital therapeutics to patients, including further expansion within women's health and oncology in the US and EU. Further, PINK!'s team will join Sidekick Health after the acquisition. 

  • Germany-based PINK! developed PINK! Coach as the first and only prescription digital therapeutic for breast cancer. It supports patients with information and daily goals in areas like exercise, diet, and mental health. The aim is to help patients manage side effects and enhance their overall quality of life during treatments.

  • Analyst QuickTake: This marks Sidekick Health’s second acquisition after acquiring aidhere, a German-based company known for its weight management app, "Zanadio," in October 2023 . This step underscores Sidekick's commitment to expanding its digital therapy options and geographical reach.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.